Louise Rodino-Klapac

CIK: 0001836218

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)3 (13.0%)

Derivative conversions

Awards (A)6 (26.1%)

Compensation grants

Other (G, F, J, C, D, …)14 (60.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SRPT

Sarepta Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (23 total)

SRPT
Sarepta Therapeutics, Inc.
Sep 4, 2026
Tax Payment(F)
Direct
21.4K shares at avg. $22.22$476K
SRPT
Sarepta Therapeutics, Inc.
Mar 11, 2026
Tax Payment(F)
Direct
948 shares at avg. $17.03$16K
SRPT
Sarepta Therapeutics, Inc.
Mar 9, 2026
Tax Payment(F)
Direct
504 shares at avg. $16.95$9K
SRPT
Sarepta Therapeutics, Inc.
Mar 9, 2026
Tax Payment(F)
Direct
895 shares at avg. $16.95$15K
SRPT
Sarepta Therapeutics, Inc.
Mar 2, 2026
Tax Payment(F)
Direct
767 shares at avg. $16.20$12K
SRPT
Sarepta Therapeutics, Inc.
Mar 2, 2026
Tax Payment(F)
Direct
3.7K shares at avg. $16.20$60K
SRPT
Sarepta Therapeutics, Inc.
Mar 1, 2026
Exercise(M)
Direct
8.1K shares-
SRPT
Sarepta Therapeutics, Inc.
Feb 25, 2026
Award(A)
Performance Stock Units
Direct
1.9K shares-
SRPT
Sarepta Therapeutics, Inc.
Nov 17, 2025
Tax Payment(F)
Direct
4.6K shares at avg. $18.42$84K
SRPT
Sarepta Therapeutics, Inc.
Sep 3, 2025
Award(A)
Direct
93.9K shares-
SRPT
Sarepta Therapeutics, Inc.
Sep 3, 2025
Award(A)
Direct
50K shares-
SRPT
Sarepta Therapeutics, Inc.
Aug 5, 2025
Award(A)
Performance Stock Units
Direct
6.3K shares-
SRPT
Sarepta Therapeutics, Inc.
Mar 10, 2025
Award(A)
Direct
8.3K shares-
SRPT
Sarepta Therapeutics, Inc.
Mar 10, 2025
Tax Payment(F)
Direct
924 shares at avg. $100.13$93K
SRPT
Sarepta Therapeutics, Inc.
Mar 10, 2025
Tax Payment(F)
Direct
2.5K shares at avg. $100.13$254K
SRPT
Sarepta Therapeutics, Inc.
Mar 7, 2025
Exercise(M)
Direct
5.5K shares-
SRPT
Sarepta Therapeutics, Inc.
Mar 7, 2025
Tax Payment(F)
Direct
514 shares at avg. $103.70$53K
SRPT
Sarepta Therapeutics, Inc.
Mar 7, 2025
Tax Payment(F)
Direct
8K shares at avg. $103.70$829K
SRPT
Sarepta Therapeutics, Inc.
Mar 6, 2025
Exercise(M)
Direct
17.5K shares-
SRPT
Sarepta Therapeutics, Inc.
Mar 4, 2025
Tax Payment(F)
Direct
1.7K shares at avg. $101.34$173K
SRPT
Sarepta Therapeutics, Inc.
Mar 3, 2025
Tax Payment(F)
Direct
715 shares at avg. $103.77$74K
SRPT
Sarepta Therapeutics, Inc.
Feb 11, 2025
Award(A)
Performance Restricted Stock Units
Direct
3.5K shares-
SRPT
Sarepta Therapeutics, Inc.
Nov 18, 2024
Tax Payment(F)
Direct
4.6K shares at avg. $102.89$469K

		Type	Shares	Price		Ownership
Sep 4, 2026	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	21,423	$22.22	$476,019	Direct
Mar 11, 2026	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	948	$17.03	$16,144	Direct
Mar 9, 2026	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	504	$16.95	$8,543	Direct
Mar 9, 2026	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	895	$16.95	$15,170	Direct
Mar 2, 2026	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	767	$16.20	$12,425	Direct
Mar 2, 2026	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	3,718	$16.20	$60,232	Direct
Mar 1, 2026	SRPT Sarepta Therapeutics, Inc.	Exercise(M)	8,125	-	$0	Direct
Feb 25, 2026	SRPT Sarepta Therapeutics, Inc.	Award(A) Performance Stock Units	1,875	-	-	Direct
Nov 17, 2025	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	4,582	$18.42	$84,400	Direct
Sep 3, 2025	SRPT Sarepta Therapeutics, Inc.	Award(A)	93,875	-	-	Direct
Sep 3, 2025	SRPT Sarepta Therapeutics, Inc.	Award(A)	50,000	-	-	Direct
Aug 5, 2025	SRPT Sarepta Therapeutics, Inc.	Award(A) Performance Stock Units	6,250	-	-	Direct
Mar 10, 2025	SRPT Sarepta Therapeutics, Inc.	Award(A)	8,276	-	-	Direct
Mar 10, 2025	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	924	$100.13	$92,520	Direct
Mar 10, 2025	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	2,539	$100.13	$254,230	Direct
Mar 7, 2025	SRPT Sarepta Therapeutics, Inc.	Exercise(M)	5,500	-	-	Direct
Mar 7, 2025	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	514	$103.70	$53,302	Direct
Mar 7, 2025	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	7,990	$103.70	$828,563	Direct
Mar 6, 2025	SRPT Sarepta Therapeutics, Inc.	Exercise(M)	17,500	-	-	Direct
Mar 4, 2025	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	1,704	$101.34	$172,683	Direct
Mar 3, 2025	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	715	$103.77	$74,196	Direct
Feb 11, 2025	SRPT Sarepta Therapeutics, Inc.	Award(A) Performance Restricted Stock Units	3,500	-	-	Direct
Nov 18, 2024	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	4,558	$102.89	$468,973	Direct

1-23 of 23 transactions

About Rodino-Klapac Louise

Rodino-Klapac Louise (SEC CIK 0001836218) files insider reports with the SEC as President, R&D and Tech Ops of Sarepta Therapeutics, Inc. (SRPT).

Signal8 holds 14 ownership filings by Rodino-Klapac Louise, all Form 4s, filed between Nov 20, 2024 and Sep 8, 2026. Those filings report 23 transactions, from Nov 18, 2024 to Sep 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Rodino-Klapac Louise's filings is in CAMBRIDGE, MA.

Recent filings by Rodino-Klapac Louise

Sep 4, 2026: Tax withholding of SRPT shares (Form 4, code F).
Mar 11, 2026: Tax withholding of SRPT shares (Form 4, code F).
Mar 9, 2026: Tax withholdings of SRPT shares (2 lines, Form 4, code F).
Mar 2, 2026: Tax withholdings of SRPT shares (2 lines, Form 4, code F).
Mar 1, 2026: Option exercise of SRPT shares (Form 4, code M).

Other insiders filing for Sarepta Therapeutics, Inc. (SRPT)

Wong Ryan Ho-Yan, Chief Financial Officer
Estepan Ian Michael, Chief Operating Officer
Rothfuss Cristin, EVP, General Counsel
SEVERINO MICHAEL, Chief Executive Officer
Boor Kathryn Jean, Director
Mayo Stephen, Director

How to read Form 4 transaction codes